Filing Flows › biote (BTMD) › Q3 2025
biote (BTMD) Q3 2025 earnings results (third quarter 2025)
10-Q filed Nov 7, 2025
biote (BTMD) reported revenue of $48.0M for the third quarter 2025 (Q3 2025), -7% from a year earlier and -2% from the quarter before. Operating margin was 17.2%, net earnings $8.2M (17.1% of revenue).
biote, Q3 2025: revenue $48.0M (-7% year over year), operating margin 17.2%, net earnings $8.2M, operating cash flow $14.1M. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $48.0M | -2% | -7% |
| Operating profit | $8.3M | -23% | -32% |
| Net earnings | $8.2M | +157% | -23% |
| Operating cash flow | $14.1M | +99% | -10% |
| Free cash flow | $13.6M | +157% | -3% |
What changed
Revenue was $48.0M in Q3 2025, down 7% year over year and down 2% from the previous quarter. Pellet Procedures Product Revenue was the largest line at 71% of revenue. Pellet Procedures Product Revenue lost $4.0M year over year (down 10%), 116% of the total change.
Operating profit was $8.3M, a 17.2% margin (down 6.5 points year over year). Total costs grew 1% against a revenue fall of 7%. Net earnings were $8.2M, down 23% year over year. The effective tax rate was -9.1%.
Operating cash flow was $14.1M (down 10% year over year), 153% of net income including minority interests. Non-cash charges added back $1.0M of depreciation and amortization and $2.4M of share-based compensation. Working capital and other items added $1.5M. Capital expenditures of $499K left free cash flow of $13.6M.
Questions
What was biote's revenue in the third quarter 2025?
biote (BTMD) reported revenue of $48.0M for the third quarter 2025 (Q3 2025), -7% from a year earlier and -2% from the quarter before.
Was biote profitable in the third quarter 2025?
Operating profit was $8.3M (17.2% of revenue) and net earnings $8.2M.
Source: biote 10-Q on SEC EDGAR.